Glaxo said to pay $460 Million to settle Avandia lawsuits
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
L.A. Times - News — GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, peopl... more info